About this test
Sequences the hotspot regions of IDH1 and IDH2. Results guide targeted therapy in AML and support the classification of gliomas.
- Clinical area
- Haematological malignancies
- Method
- Sanger sequencing
- Sample
- EDTA whole blood · Bone marrow · FFPE tissue block
- Report languages
- EN · AR · RU
When to order
Newly diagnosed or relapsed AML, and classification of diffuse gliomas.
Results are reported to the ordering physician and should be interpreted in clinical context.
Request this test
Offer this test to your patients.
Contract pricing and turnaround times are provided on request for laboratories and clinics.
Haematological malignancies
Other tests in this area
- JAK2 V617FMyeloproliferative neoplasms→
- JAK2 exon 12Polycythaemia vera→
- CALR exon 9Essential thrombocythaemia, myelofibrosis→
- MPL W515Essential thrombocythaemia, myelofibrosis→
- BCR::ABL1Chronic myeloid leukaemia, ALL→
- FLT3-ITD / TKDAcute myeloid leukaemia→
- NPM1Acute myeloid leukaemia→
- KIT D816VSystemic mastocytosis→
- Leukaemia fusion panelAcute leukaemia classification→